MedPath
FDA Product

Zortress

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Zortress

0078-0415

Regulatory Information

0078-0415

NDA021560

C73594

August 10, 2018

USA

These highlights do not include all the information needed to use ZORTRESS safely and effectively. See full prescribing information for ZORTRESS. ZORTRESS (everolimus) tablets, for oral useInitial U.S. Approval: 2010

HUMAN PRESCRIPTION DRUG LABEL

26

Company Information

002147023

Active Ingredients

EVEROLIMUS

Quantity: 0.75 mg in 1 1

Code: 9HW64Q8G6G

Class Code: ACTIB

Inactive Ingredients

CROSPOVIDONE

Code: 2S7830E561

Class Code: IACT

BUTYLATED HYDROXYTOLUENE

Code: 1P9D0Z171K

Class Code: IACT

ANHYDROUS LACTOSE

Code: 3SY5LH9PMK

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

LACTOSE MONOHYDRATE

Code: EWQ57Q8I5X

Class Code: IACT

HYPROMELLOSES

Code: 3NXW29V3WO

Class Code: IACT

Active Moieties

EVEROLIMUS

Code: 9HW64Q8G6G

© Copyright 2025. All Rights Reserved by MedPath